Science Museum Blog Reports on Genetic Editing Breakthrough for Disease Treatment
A recent article from the Science Museum Blog discusses advances in genetic medicine, focusing on a new approach called PERT (prime-editing-installed suppressor tRNAs). Developed by Prof. David Liu and colleagues at the Broad Institute of MIT and Harvard, this technique aims to address nonsense mutations—a common type of genetic error causing diseases like cystic fibrosis and Duchenne muscular dystrophy. The method uses prime editing, a CRISPR-derived technology, to install suppressor tRNAs that can override premature stop signals in DNA, potentially restoring protein function. Initial tests in cell models and mice, including for Hurler syndrome, showed promising results with restored protein levels and symptom reduction. The research, published in Nature, highlights the potential for a single therapy to treat multiple genetic conditions, though clinical application faces challenges such as delivery, safety, and regulatory approval. The article also references historical context with DNA models from the Science Museum's collection.
Key facts
- Prof. David Liu and team developed PERT to target nonsense mutations in genetic diseases
- The technique uses prime editing to install suppressor tRNAs, potentially treating conditions like cystic fibrosis and Duchenne muscular dystrophy
- Initial studies in cell models and mice showed restored protein function with minimal off-target effects
- Research published in Nature, with clinical trials possible within 5-10 years
- The article references DNA-related artifacts from the Science Museum's collection
Entities
Institutions
- Science Museum
- Broad Institute of MIT and Harvard
- Children's Hospital of Philadelphia
- University of Pennsylvania
Locations
- Cambridge, Massachusetts